Chemistry Reference
In-Depth Information
12. Rahman, Z., Zidan, A.S., and Khan, M.A. (2010) Risperidone solid dispersion for orally
disintegrating tablet: its formulation design and non-destructive methods of evaluation.
Int.
J. Pharm.
, 400(1-2):49-58.
13. Rahman, Z., Zidan, A.S., Samy, R., Sayeed, V.A., and Khan, M.A. (2012) Improvement of
physicochemical properties of an antiepileptic drug by salt engineering.
AAPS PharmSciTech.
,
3(3):793-801.
14. Rahman, Z., Siddiqui, A., and Khan, M.A. (2013) Assessing the impact of nimodipine
devitri
cation in the ternary cosolvent system through quality by design approach.
Int. J.
Pharm.
, 455(1-2):113-123.
15. Rahman, Z., Zidan, A.S., and Khan, M.A. (2010) Formulation and evaluation of a protein-
loaded solid dispersions by non-destructive methods.
AAPS J.
, 12(2):158-170.
16. Zidan, A.S., Rahman, Z., Sayeed, V., Raw, A., Yu, L., and Khan, M.A. (2012) Crystallinity
evaluation of
tacrolimus solid dispersions by chemometric analysis.
Int. J. Pharm.
,
423(2):341-350.
17. Rahman, Z., Siddiqui, A., and Khan, M.A. (2013) Characterization of a nonribosomal peptide
antibiotic solid dispersion formulation by process analytical technologies sensors.
J. Pharm.
Sci.
, 102(12):4337-4346.
18. Rahman, Z. and Khan, M.A. (2013) Hunter screening design to understand the product
variability of solid dispersion formulation of a peptide antibiotic.
Int. J. Pharm.
,
456(2):572-82.
19. Van den Mooter, G. (2009) Solid dispersions as a formulation strategy for poorly soluble
compounds.
20th Annual Symposium of the Finish Society of Physical Pharmacy, Vithi,
Finland, January 28-29, 2009
.
20. Patel, V.I. and Dave R.H. (2013) Evaluation of colloidal solid dispersions: physiochemical
considerations and
in vitro
release profile.
AAPS PharmSciTech.
, 14(2):620-628.
21. Janssens, S. and Van den Mooter, G. (2009) Review: physical chemistry of solid dispersions.
J. Pharm. Pharmacol.
, 61(12), 1571-1586.
22. U.S. Department of Health and Human Services (2005)
Guidance for Industry. Nonclinical
Studies for the Safety Evaluation of Pharmaceutical Excipients
.
23. Liu, H., Pan, W.S., Zhou, L.L., and Zhang, Z.H. (2007) Preparation of budesonide-poly
(ethylene oxide) solid dispersions using supercritical carbon dioxide and
in vitro
evaluation.
Yao Xue Xue Bao
, 42(2):206-210.
24. Repka, M.A. and McGinity, J.W. (2000) Influence of Vitamin E TPGS on the properties of
hydrophilic films produced by hot-melt extrusion.
Int. J. Pharm.
, 202(1-2):63-70.
25. Newman, A., Engers, D., Bates, S., Ivanisevic, I., Kelly, R.C., and Zografi, G. (2008)
Characterization of amorphous API: polymer mixtures using X-ray powder diffraction.
J. Pharm. Sci.
, 97(11):4840-4856.
26. Andrews, G.P., Abu-Diak, O., Kusmanto, F., Hornsby, P., Hui, Z., and Jones, D.S. (2010)
Physicochemical characterization and drug-release properties of celecoxib hot-melt extruded
glass solutions.
J. Pharm. Pharmacol.
, 62(11):1580-1590.
27. Sakurai, A., Sako, K., and Maitani, Y. (2012) Influence of manufacturing factors on physical
stability and solubility of solid dispersions containing a low glass transition temperature drug.
Chem. Pharm. Bull.
, 60(11):1366-1371.
28. Patterson, J.E., James, M.B., Forster, A.H., Lancaster, R.W., Butler, J.M., and Rades, T.
(2005) The influence of thermal and mechanical preparative techniques on the amorphous state
of four poorly soluble compounds.
J. Pharm. Sci.
, 94(9):1998-2012.
